Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04072952
Brief Title: A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (mBC)

First Submitted : August 27, 2019
First Submitted that Met QC Criteria : August 27, 2019
First Posted : August 28, 2019

Last Update Submitted that Met QC Criteria : December 10, 2020
Last Update Posted : December 14, 2020